AVA-7000

N/A

Report date: 2025/01/26 17:00:18

Base Information

Drug NameAVA-7000
Drug Alias NameSeprase stimulator (Avacta/Tufts University School of Medicine)Seprase stimulator (Avacta/Tufts University School of Medicine)AVA-7000
ClassificationBiologics
Mechanisms of ActionProlyl endopeptidase FAP stimulants
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A